JP2008503207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008503207A5 JP2008503207A5 JP2007515398A JP2007515398A JP2008503207A5 JP 2008503207 A5 JP2008503207 A5 JP 2008503207A5 JP 2007515398 A JP2007515398 A JP 2007515398A JP 2007515398 A JP2007515398 A JP 2007515398A JP 2008503207 A5 JP2008503207 A5 JP 2008503207A5
- Authority
- JP
- Japan
- Prior art keywords
- antiviral
- pharmaceutical composition
- nucleic acid
- acid molecule
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57605604P | 2004-06-01 | 2004-06-01 | |
| US60/576,056 | 2004-06-01 | ||
| PCT/US2005/018778 WO2005118627A2 (en) | 2004-06-01 | 2005-05-27 | Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008503207A JP2008503207A (ja) | 2008-02-07 |
| JP2008503207A5 true JP2008503207A5 (https=) | 2008-06-19 |
| JP4776620B2 JP4776620B2 (ja) | 2011-09-21 |
Family
ID=35463427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007515398A Expired - Lifetime JP4776620B2 (ja) | 2004-06-01 | 2005-05-27 | グリフィスシン、グリコシル化耐性グリフィスシン、ならびに関連する抱合体、組成物、核酸、ベクター、宿主細胞、製造方法および使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7884178B2 (https=) |
| EP (1) | EP1740605B1 (https=) |
| JP (1) | JP4776620B2 (https=) |
| AU (1) | AU2005250429B2 (https=) |
| CA (1) | CA2567728C (https=) |
| IL (1) | IL179236A (https=) |
| NZ (1) | NZ551375A (https=) |
| WO (1) | WO2005118627A2 (https=) |
| ZA (1) | ZA200609573B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1976596B1 (en) * | 2005-12-01 | 2013-07-31 | Government Of The United States Of America, As Represented By The Secretary, Department of Health Human Services | Anti-viral griffithsin compounds, compositions, and methods of use |
| JP5251143B2 (ja) * | 2007-07-30 | 2013-07-31 | 宇部興産株式会社 | 多価アルコールおよびその製造方法 |
| US8911728B2 (en) | 2010-05-21 | 2014-12-16 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins |
| EP2968453B1 (en) | 2013-03-15 | 2019-12-04 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Stabilized single human cd4 domains and fusion proteins |
| CA2914498C (en) * | 2013-06-05 | 2021-11-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Monomeric griffithsin tandemers |
| CA2935123A1 (en) | 2014-01-09 | 2015-07-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-viral cnidarins |
| WO2016054250A1 (en) * | 2014-10-01 | 2016-04-07 | Cascadia Life Sciences Llc | Anti-viral peptides |
| AU2016219434B2 (en) * | 2015-02-10 | 2020-07-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Griffithsin mutants |
| EP3590961A1 (en) | 2015-03-25 | 2020-01-08 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Bispecific multivalent fusion proteins |
| WO2018039626A1 (en) | 2016-08-25 | 2018-03-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human single domain antibodies targeting cd16a to mediate adcc |
| WO2019108656A1 (en) | 2017-11-28 | 2019-06-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microbicidal composition |
| EP4028041A4 (en) * | 2019-09-10 | 2023-09-13 | University Of Louisville Research Foundation, Inc. | ANTIVIRAL COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE |
| EP4108251A1 (en) | 2021-06-22 | 2022-12-28 | Solmic Biotech GmbH | Griffithsin for use in a method of preventing or treating infections with respiratory viruses |
| EP4499857A1 (en) | 2022-03-24 | 2025-02-05 | Danisco US Inc. | Compositions and methods for industrial scale production and recovery of lectins |
| CN119997966A (zh) | 2022-09-20 | 2025-05-13 | 国际N&H丹麦有限公司 | 变体抗病毒多肽 |
| CN121752712A (zh) | 2023-06-30 | 2026-03-27 | 丹尼斯科美国公司 | 用于凝集素工业规模生产的重组真菌细胞及其方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
-
2005
- 2005-05-27 CA CA2567728A patent/CA2567728C/en not_active Expired - Lifetime
- 2005-05-27 AU AU2005250429A patent/AU2005250429B2/en not_active Expired
- 2005-05-27 JP JP2007515398A patent/JP4776620B2/ja not_active Expired - Lifetime
- 2005-05-27 WO PCT/US2005/018778 patent/WO2005118627A2/en not_active Ceased
- 2005-05-27 NZ NZ551375A patent/NZ551375A/en not_active IP Right Cessation
- 2005-05-27 EP EP05804849A patent/EP1740605B1/en not_active Expired - Lifetime
- 2005-05-27 US US11/569,813 patent/US7884178B2/en active Active
-
2006
- 2006-11-13 IL IL179236A patent/IL179236A/en active IP Right Grant
- 2006-11-17 ZA ZA200609573A patent/ZA200609573B/xx unknown
-
2011
- 2011-02-07 US US13/022,289 patent/US8394764B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008503207A5 (https=) | ||
| US10442845B2 (en) | Interferon analogs | |
| Van der Strate et al. | Antiviral activities of lactoferrin | |
| Wills | Clinical pharmacokinetics of interferons | |
| JP2010254723A5 (ja) | ホスファチジルエタノールアミンに結合するペプチド、ならびにウイルス感染およびガンの処置におけるその使用 | |
| JP2023162283A5 (https=) | ||
| US6361769B1 (en) | Stimulation of host defense mechanisms against viral challenges | |
| JP2001520238A5 (https=) | ||
| JP2012501959A5 (https=) | ||
| RU2447083C1 (ru) | НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ | |
| Ramos et al. | Forms and methods for interferon’s encapsulation | |
| US20210309973A1 (en) | Bacteriophage-Based Antibodies and Binders | |
| JP2011508785A5 (https=) | ||
| JP2014525939A (ja) | ペグインターフェロンλ１複合体 | |
| JPWO2021188576A5 (https=) | ||
| JP2008532995A (ja) | 組換え高効率複合インターフェロンの使用方法 | |
| JP2018052837A (ja) | エボラウイルスワクチン | |
| US20250161335A1 (en) | Drug and Method for Nucleoside (Acid) Drug Therapy of Limiting Chronic Hepatitis B | |
| DK0871738T3 (da) | Rekombinante virale pseudopartikler og deres anvendelse som vacciner eller antitumor-lægemidler | |
| ES2207753T3 (es) | Nuevos inhibidores de la hepatitis b. | |
| WO2021236045A1 (en) | Vaccine for prevention of and/or immunization against sars-cov-2 | |
| CA2253902A1 (en) | Stimulation of host defense mechanisms against viral challenges | |
| US20230131808A1 (en) | Pegylated interferon tau and compositions and methods thereof | |
| JP2003514518A5 (https=) | ||
| AP255A (en) | A method of inoculation with an antigenic peptide. |